Omnilink Elite Vascular Balloon-Expandable Stent System
Abbott Vascular-Cardiac Therapies · Decision date Jan 12, 2026
What did the FDA approve?
FDA records P110043/S015 as a supplement to PMA P110043, with the supplement type “Special (Immediate Track)”. The recorded decision is approval, dated Jan 12, 2026.
FDA approval order statement
Approval for updates to the device Instructions for Use (IFU) and patient guide including updates to the contraindications, warnings, precautions, procedural updates, and MRI Safety information
- Regulatory pathway
- PMA supplement
- Supplement type
- Special (Immediate Track)
- Clinical specialty
- Cardiovascular
- Decision date
- Jan 12, 2026
- FDA change category
- Labeling Change - Indications/instructions/shelf life/tradename
Regulatory record facts
- Identifier
- P110043/S015
- Regulatory pathway
- PMA supplement
- Applicant
- Abbott Vascular-Cardiac Therapies
- Product code
- NIO
- Decision code
- APPR
- Decision date
- Jan 12, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: STENT, ILIAC.
- Applicant
- Abbott Vascular-Cardiac Therapies
- Product code
- NIO
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P110043/S015 received
Application receipt date recorded by FDA.
P110043/S015 · FDA decision
Special (Immediate Track)
Timeline entries are records held by MedtechLedger for P110043. View FDA’s full supplement list.
Related devices and submissions
Explore the linked device profile
Other records with product code NIO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Cook Ireland, Ltd. | PMA supplement | Nov 6, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
S.M.A.R.T. CONTROL Nitinol Stent SystemP020036/S061 | Cordis US Corporation | PMA supplement | Oct 15, 2026 | FDA |
| Biotronik AG | PMA supplement | Sep 11, 2026 | FDA | |
Epic Vascular Self-Expanding Stent SystemP110035/S079 | Boston Scientific Corp | PMA supplement | Aug 21, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Vascular-Cardiac Therapies
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 3200 Lakeside Dr., Santa Clara, CA, 95054
Sources and methodology
- Original FDA record: P110043/S015
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



